Pelvic Floor Electric Stimulator Market To Reach $539.38 Million By 2030

Pelvic Floor Electric Stimulator Market Growth & Trends

The global pelvic floor electric stimulator market size is anticipated to reach USD 539.38 million by 2030, registering a CAGR of 11.9% from 2023 to 2030, according to a new report by Grand View Research, Inc. Increasing prevalence of Urinary Incontinence (UI), rising investment in research and development by key players, and the growing number of awareness initiatives are anticipated to boost the market growth. Increasing cases of chronic diseases and UI are primary factors that are expected to drive market growth. According to the NHS, around 61% of the male population is suffering from lower urinary tract infections and around 34% of women are living with some type of UI. This disorder costs around USD 301.40 million per year to the NHS. Thereby, contributing to market growth.

Moreover, the geriatric population is at a higher risk for developing various neurological conditions, such as stroke, prostate cancer, and Alzheimer’s, which may affect the lower urinary tract. This factor is anticipated to be one of the high growth rendering drivers of this market. As per the WHO, the global population of people aged 65 years and above is expected to rise from 7.00% in 2000 to 16.00% in 2050. This is expected to drive the market at a global level.Furthermore, the launch of technologically advanced products with comparatively lower prices is expected to drive market growth. For instance, in February 2020, Atlantic Therapeutics received U.S. FDA, clearance for the over-the-counter device INNOVO-a wearable and non-invasive pelvic floor muscle stimulator for treating stress urinary incontinence.

 Request a free sample copy or view report summary: Pelvic Floor Electric Stimulator Market Report

Pelvic Floor Electric Stimulator Market Report Highlights

• Based on the applications, the urinary incontinence segment dominated the market in 2022 with a share of 84.9% owing to the high number of patients suffering from UI globally

• North America dominated the market with the highest revenue share of 38.9% in 2022 owing to the rising incidence of targeted diseases, such as bladder obstruction, UI, and Benign Prostatic Hyperplasia (BPH)

• Moreover, this region is one of the most advanced regions globally with innovative technologies & infrastructure, resulting in significant healthcare facilities and patient care

• However, Asia Pacific is expected to lead the market from 2023 to 2030. The rising risk of Urinary Tract Infection (UTI) in women with increasing age, vaginal deliveries, and surgeries are driving the market growth in this region

Pelvic Floor Electric Stimulator Market Segmentation

Grand View Research has segmented the global pelvic floor electric stimulator market based on application and region:

Pelvic Floor Electric Stimulator Application Outlook (Revenue, USD Million, 2018 - 2030)

• Urinary Incontinence

• Neurodegenerative Disorders

• Sexual Dysfunction

Pelvic Floor Electric Stimulator Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of Pelvic Floor Electric Stimulator Market

• Zynex Inc.

• TensCare Ltd.

• Verity Medical Ltd.

• InControl Medical

• The Prometheus Group

• Laborie, Inc.

• ActivLife Technologies

• Athena Feminine Technologies

• Atlantic Therapeutics

• Renovia Inc.